|
1
|
Tseng HC, Liu CT, Ho JC and Lin SH:
Necrolytic migratory erythema and glucagonoma rising from
pancreatic head. Pancreatology. 13:455–457. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chastain MA: The glucagonoma syndrome: a
review of its features and discussion of new perspectives. Am J Med
Sci. 321:306–320. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wermers RA, Fatourechi V, Wynne AG, Kvols
LK and Lloyd RV: The glucagonoma syndrome. Clinical and pathologic
features in 21 patients. Medicine (Baltimore). 75:53–63. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Soga J and Yakuwa Y:
Glucagonomas/diabetico-dermatogenic syndrome (DDS): a statistical
evaluation of 407 reported cases. J Hepatobiliary Pancreat Surg.
5:312–319. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Eldor R, Glaser B, Fraenkel M, Doviner V,
Salmon A and Gross DJ: Glucagonoma and the glucagonoma syndrome -
cumulative experience with an elusive endocrine tumour. Clin
Endocrinol (Oxf). 74:593–598. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lo CH, Ho CL and Shih YL: Glucagonoma with
necrolytic migratory erythema exhibiting responsiveness to
subcutaneous octreotide injections. QJM. 107:157–158. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stacpoole PW: The glucagonoma syndrome:
clinical features, diagnosis and treatment. Endocr Rev. 2:347–361.
1981. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lefèbvre PJ: Glucagon and its family
revisited. Diabetes Care. 18:715–730. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Charlton MR, Adey DB and Nair KS: Evidence
for a catabolic role of glucagon during an amino acid load. J Clin
Invest. 98:90–99. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
van Beek AP, de Haas ER, van Vloten WA,
Lips CJ, Roijers JF and Canninga-van Dijk MR: The glucagonoma
syndrome and necrolytic migratory erythema: a clinical review. Eur
J Endocrinol. 151:531–537. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shi W, Liao W, Mei X, Xiao Q, Zeng Y and
Zhou Q: Necrolytic migratory erythema associated with glucagonoma
syndrome. J Clin Oncol. 28:e329–e331. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Remes-Troche JM, Garcia-de-Acevedo B,
Zuniga-Varga J, Avila-Funes A and Orozco-Topete R: Necrolytic
migratory erythema: a cutaneous clue to glucagonoma syndrome. J Eur
Acad Dermatol Venereol. 18:591–595. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kheir SM, Omura EF, Grizzle WE, Herrera GA
and Lee I: Histologic variation in the skin lesions of the
glucagonoma syndrome. Am J Surg Pathol. 10:445–453. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mullans EA and Cohen PR: Iatrogenic
necrolytic migratory erythema: a case report and review of
nonglucagonoma-associated necrolytic migratory erythema. J Am Acad
Dermatol. 38:866–873. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yao JC, Eisner MP, Leary C, Dagohoy C,
Phan A, Rashid A, Hassan M and Evans DB: Population-based study of
islet cell carcinoma. Ann Surg Oncol. 14:3492–3500. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Radny P, Eigentler TK, Soennichsen K,
Overkamp D, Raab HR, Viebahn R, Mueller-Horvart C, Sotlar K and
Rassner G: Metastatic glucagonoma: treatment with liver
transplantation. J Am Acad Dermatol. 54:344–347. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Poggi G, Villani L and Bernardo G:
Multimodality treatment of unresectable hepatic metastases from
pancreatic glucagonoma. Rare Tumors. 1:e62009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Smith AP, Doolas A and Staren ED: Rapid
resolution of necrolytic migratory erythema after glucagonoma
resection. J Surg Oncol. 61:306–309. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Elsborg L and Glenthoj A: Effect of
somatostatin in necrolytic migratory erythema of glucagonoma. Acta
Med Scand. 218:245–249. 1985. View Article : Google Scholar : PubMed/NCBI
|
